. of migraine. more than 4 million of them have at least 15 migraine days each month. even though many drugs prevent and treat these headaches,
.erenumab (aimovig) is the first of four new migraine drugs in the pipeline that target calcitonin gene-related peptide (cgrp), a molecule that's produced in nerve cells of the
.